ANAVEX LIFE SCIENCES CORP. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anavex Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Anavex Life Sciences Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.3M, a 13.3% decline year-over-year.
  • Anavex Life Sciences Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$52.9M, a 5.16% increase year-over-year.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2024 was -$52.9M, a 5.16% increase from 2023.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$55.8M, a 9.36% decline from 2022.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$51M, a 21.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$52.9M -$14.3M -$1.69M -13.3% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-23
Q2 2024 -$51.2M -$14.7M -$1.2M -8.85% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$50M -$12.5M +$1.67M +11.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$51.7M -$11.3M +$4.09M +26.6% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 -$55.8M -$12.7M +$2.63M +17.2% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-23
Q2 2023 -$58.4M -$13.5M -$1.07M -8.61% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$57.3M -$14.2M -$2.67M -23.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$54.6M -$15.4M -$3.66M -31.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 -$51M -$15.3M Jul 1, 2022 Sep 30, 2022 10-K 2023-11-27
Q2 2022 -$12.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$11.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$11.7M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q2 2015 -$3.78M -$1.51M -$514K -51.5% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 -$3.27M -$858K +$163K +15.9% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 -$3.43M -$771K -$461K -149% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-17
Q3 2014 -$2.97M -$639K +$829K +56.5% Jul 1, 2014 Sep 30, 2014 10-K 2014-12-29
Q2 2014 -$3.8M -$999K -$873K -693% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$2.93M -$1.02M -$894K -703% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$2.03M -$310K +$106K +25.6% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$2.14M -$1.47M -$829K -130% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 -$1.31M -$126K +$572K +81.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$1.88M -$127K +$668K +84% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-30
Q4 2012 -$2.55M -$416K +$1.77M +81% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$4.32M -$639K +$587K +47.9% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-30
Q2 2012 -$4.91M -$698K +$939K +57.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.85M -$796K +$1.15M +59.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-17
Q4 2011 -$7M -$2.19M -$819K -59.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$6.18M -$1.23M Jul 1, 2011 Sep 30, 2011 10-K 2012-12-31
Q2 2011 -$1.64M -$334K -25.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 -$1.95M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$1.37M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 -$1.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.